Related Experiment Videos
Liver transplantation for malignant tumors
B Koneru1, A Cassavilla, J Bowman
1Department of Surgery, University of Pittsburgh, Pennsylvania.
Gastroenterology Clinics of North America
|March 1, 1988
Abstract:
As reviewed herein, the current results of liver transplantation for malignant tumors are suboptimal. Progress depends on development of other modalities of adjunctive therapy.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.
bioRxiv : the preprint server for biology·2026
Continent-wide effects of urbanization on bird and mammal genetic diversity.
Proceedings. Biological sciences·2020
Role of targeted magnetic resonance imaging sequences in the surgical management of anterior skull base pathology.
The Journal of laryngology and otology·2016
Food and Drug Administration-Approved Fecal Microbiota-Based Therapies for Recurrent Clostridioides difficile Infection.
Gastroenterology clinics of North America·2026
Non-Fecal Microbiota Transplantation Strategies for Treatment of Recurrent Clostridioides difficile Infection.
Gastroenterology clinics of North America·2026
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Gastroenterology clinics of North America·2026
Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.
Gastroenterology clinics of North America·2026
Treatment of Severe and Fulminant Clostridioides difficile Infections.
Gastroenterology clinics of North America·2026
Non-Severe Clostridium difficile Infection.
Gastroenterology clinics of North America·2026
A Rat Excisional Wound Model for Investigating Therapeutics in Critical-Size Skin Wounds.
Journal of visualized experiments : JoVE·2026
Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review.
Endocrine oncology (Bristol, England)·2026
Combination of Palladium Nanoparticles and Tubastatin-A Potentiates Apoptosis in Human Breast Cancer Cells: A Novel Therapeutic Approach for Cancer [Retraction].
International journal of nanomedicine·2026